Pitney-Bowes (PBI) Announces Acquisition of CrescoData
Get Alerts PBI Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3.8%
Revenue Growth %: -1.6%
Join SI Premium – FREE
Pitney Bowes Inc. (NYSE: PBI), a global shipping and mailing company that provides technology, logistics, and financial services, today announced the acquisition of CrescoData, a Platform-as-a-Service (PaaS) business in the commerce space. Terms of the deal were not disclosed.
Based in Singapore, CrescoData’s Commerce Connect Platform provides integration to over 85 commerce channels through a single API, and enables mapping and automating of product, stock, and order data between the platforms. This strategic investment enhances the Company’s product offerings for mid-high volume Ecommerce shippers. It also accelerates Pitney Bowes Enterprise Shipping and Locker go-to-market strategy for the Retail and Pharmacy verticals.
“Shipping is a significant growth area for Pitney Bowes as our Shipping Index predicts volumes will double in the next five years. CrescoData’s state-of-the-art technology is a perfect complement to our SendPro shipping portfolio,” said Jason Dies, Senior Vice President and President, Sending Technology Solutions, Pitney Bowes. “Integrating CrescoData into the Pitney Bowes family allows us to better serve our clients with broader offerings and enhances our end-to-end solution capabilities.”
“Our team is delighted to be joining Pitney Bowes. This integration not only expands the offerings for Pitney Bowes, but allows us to pursue new clients backed by the strength of a trusted company with a long history of innovating,” said Anna Trybocka, founder of CrescoData. “To be part of a company squarely focused on the shipping opportunity and providing value for its clients creates exciting opportunities for growth.”
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cronos Group extends cannabis acquisition deadline to October 2026
- Cosmos Health unit secures 2.5M-unit drug manufacturing deal with Viofar
- EverCommerce raises share repurchase program to $325 million
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsRelated Entities
Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share